2023 Q1 Form 10-K Financial Statement

#000143774923006171 Filed on March 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $26.61M $20.17M $50.21M
YoY Change 651.21% 225.86% 183.56%
% of Gross Profit
Research & Development $464.0K $231.0K $4.101M
YoY Change -69.97% -85.7% 153.93%
% of Gross Profit
Depreciation & Amortization $38.00K $33.00K $162.0K
YoY Change -19.15% -31.25% -11.96%
% of Gross Profit
Operating Expenses $27.11M $20.44M $54.48M
YoY Change 428.05% 160.22% 179.26%
Operating Profit -$27.11M -$54.48M
YoY Change 428.05% 179.26%
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$237.0K $1.510M -$5.596M
YoY Change -96.24% -988.24% 121.01%
Pretax Income -$27.35M -$18.93M -$60.07M
YoY Change 139.11% 135.88% 172.57%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$27.35M -$25.43M -$60.07M
YoY Change 139.11% 216.96% 172.57%
Net Earnings / Revenue
Basic Earnings Per Share -$0.23 -$0.65
Diluted Earnings Per Share -$0.23 -$0.18 -$0.65
COMMON SHARES
Basic Shares Outstanding 150.6M 144.4M 130.1M
Diluted Shares Outstanding 146.9M 130.1M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.14M $62.79M $62.79M
YoY Change 128.74% 145.73% 145.73%
Cash & Equivalents $51.14M $62.79M $62.79M
Short-Term Investments
Other Short-Term Assets $468.0K $107.0K $619.0K
YoY Change 27.87% -74.4% 86.45%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $52.71M $63.94M $63.41M
YoY Change 125.39% 142.31% 144.97%
LONG-TERM ASSETS
Property, Plant & Equipment $243.9M $218.6M $220.1M
YoY Change 39.22% 25.79% 26.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $30.11M $28.37M
YoY Change 32.86% 33.13%
Total Long-Term Assets $275.2M $248.5M $249.0M
YoY Change 38.79% 26.96% 26.91%
TOTAL ASSETS
Total Short-Term Assets $52.71M $63.94M $63.41M
Total Long-Term Assets $275.2M $248.5M $249.0M
Total Assets $327.9M $312.4M $312.4M
YoY Change 47.92% 40.67% 40.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.854M $1.084M $1.084M
YoY Change 259.3% 285.77% 285.77%
Accrued Expenses $29.61M $24.28M $24.28M
YoY Change 809.59% 280.16% 280.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $34.89M $25.36M $25.37M
YoY Change 381.67% 208.3% 280.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $23.00M $23.00M $30.25M
YoY Change 0.0% 0.0% 11.44%
Total Long-Term Liabilities $23.00M $23.00M $30.25M
YoY Change 0.0% 0.0% 11.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.89M $25.36M $25.37M
Total Long-Term Liabilities $23.00M $23.00M $30.25M
Total Liabilities $61.94M $55.62M $55.62M
YoY Change 63.59% 64.48% 64.48%
SHAREHOLDERS EQUITY
Retained Earnings -$257.5M -$230.1M
YoY Change 41.86% 35.32%
Common Stock $15.00K $14.00K
YoY Change 25.0% 16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.634M $4.587M
YoY Change 160.48% 248.82%
Treasury Stock Shares $991.1K
Shareholders Equity $56.84M $54.37M $256.8M
YoY Change
Total Liabilities & Shareholders Equity $327.9M $312.4M $312.4M
YoY Change 47.92% 40.67% 40.67%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$27.35M -$25.43M -$60.07M
YoY Change 139.11% 216.96% 172.57%
Depreciation, Depletion And Amortization $38.00K $33.00K $162.0K
YoY Change -19.15% -31.25% -11.96%
Cash From Operating Activities -$23.19M -$12.12M -$40.08M
YoY Change 127.44% 112.25% 123.14%
INVESTING ACTIVITIES
Capital Expenditures $21.53M $29.87M $33.75M
YoY Change 1538.36% -645.31% 178.84%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$23.40M -$29.87M -$40.89M
YoY Change 675.7% 445.31% 120.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$111.7M
YoY Change 40826.01%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $34.94M -4.447M $118.2M
YoY Change 248.81% 88840.0% 199.71%
NET CHANGE
Cash From Operating Activities -$23.19M -12.12M -$40.08M
Cash From Investing Activities -$23.40M -29.87M -$40.89M
Cash From Financing Activities $34.94M -4.447M $118.2M
Net Change In Cash -$11.65M -46.43M $37.24M
YoY Change 264.68% 314.92% 1164.84%
FREE CASH FLOW
Cash From Operating Activities -$23.19M -$12.12M -$40.08M
Capital Expenditures $21.53M $29.87M $33.75M
Free Cash Flow -$44.71M -$41.99M -$73.83M
YoY Change 288.54% 18155.22% 145.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
480000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
480000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
143500000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
143500000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120800000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
120800000
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
991089
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
346126
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-19507000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-22039000 usd
CY2021 us-gaap Dividends Preferred Stock
DividendsPreferredStock
18294000 usd
CY2021 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
63000 usd
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40396000 usd
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
678000 usd
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
624000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Open Tax Year
OpenTaxYear
2019 2020 2021 2022
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-36842
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5723951
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1000 Louisiana Street, Suite 3900
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
CY2022 dei City Area Code
CityAreaCode
713
CY2022 dei Local Phone Number
LocalPhoneNumber
574-1880
CY2022 dei Security12b Title
Security12bTitle
Common stock $0.0001 par value
CY2022 dei Trading Symbol
TradingSymbol
NEXT
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
134300000 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
150573984
CY2022 dei Auditor Firm
AuditorFirmId
248
CY2022 dei Auditor Name
AuditorName
GRANT THORNTON LLP
CY2022 dei Auditor Location
AuditorLocation
Houston, Texas
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
62789000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25552000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1149000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
835000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
63938000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
26387000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
218646000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173816000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1474000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
590000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28372000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21312000 usd
CY2022Q4 us-gaap Assets
Assets
312430000 usd
CY2021Q4 us-gaap Assets
Assets
222105000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1084000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
281000 usd
CY2022Q4 next Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
23184000 usd
CY2021Q4 next Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
5973000 usd
CY2022Q4 next Current Common Stock Warrant Liabilities
CurrentCommonStockWarrantLiabilities
0 usd
CY2021Q4 next Current Common Stock Warrant Liabilities
CurrentCommonStockWarrantLiabilities
1376000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1093000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
596000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25361000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8226000 usd
CY2022Q4 next Non Current Common Stock Warrant Liabilities
NonCurrentCommonStockWarrantLiabilities
6790000 usd
CY2021Q4 next Non Current Common Stock Warrant Liabilities
NonCurrentCommonStockWarrantLiabilities
2587000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
465000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23000000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
55616000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
33813000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
14000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4587000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1315000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
289084000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
191264000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-230140000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170069000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
54371000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19892000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
312430000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
222105000 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Revenues
Revenues
0 usd
CY2022 next General And Administrative Expense Recovery
GeneralAndAdministrativeExpenseRecovery
49093000 usd
CY2021 next General And Administrative Expense Recovery
GeneralAndAdministrativeExpenseRecovery
16803000 usd
CY2022 next Development Expense
DevelopmentExpense
4101000 usd
CY2021 next Development Expense
DevelopmentExpense
1615000 usd
CY2022 next Land Option And Lease Expense
LandOptionAndLeaseExpense
1119000 usd
CY2021 next Land Option And Lease Expense
LandOptionAndLeaseExpense
905000 usd
CY2022 us-gaap Depreciation
Depreciation
162000 usd
CY2021 us-gaap Depreciation
Depreciation
184000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
54475000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
19507000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-54475000 usd
CY2022 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
-5747000 usd
CY2021 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
-2533000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
151000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5596000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2532000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-60071000 usd
CY2022 us-gaap Dividends Preferred Stock
DividendsPreferredStock
24282000 usd
CY2022 us-gaap Temporary Equity Dividends Adjustment
TemporaryEquityDividendsAdjustment
-0 usd
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-84353000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
130136000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119201000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
60432000 usd
CY2021 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards
-4541000 usd
CY2021 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
284000 usd
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
316000 usd
CY2021 next Adjustments To Additional Paid In Capital Warrants Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantsExercised
4365000 usd
CY2021 next Preferred Stock Dividends
PreferredStockDividends
-18294000 usd
CY2021 next Adjustments To Additional Paid In Capital Deemed Dividends
AdjustmentsToAdditionalPaidInCapitalDeemedDividends
-63000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-22039000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19892000 usd
CY2022 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards
7472000 usd
CY2022 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3272000 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
111068000 usd
CY2022 next Adjustments To Additional Paid In Capital Warrants Exercised
AdjustmentsToAdditionalPaidInCapitalWarrantsExercised
3564000 usd
CY2022 next Preferred Stock Dividends
PreferredStockDividends
-24282000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-60071000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
54371000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-60071000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-22039000 usd
CY2022 us-gaap Depreciation
Depreciation
162000 usd
CY2021 us-gaap Depreciation
Depreciation
184000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
7472000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
-4313000 usd
CY2022 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
-5747000 usd
CY2021 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
-2533000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
756000 usd
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
551000 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
354000 usd
CY2021 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1416000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
314000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
186000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
684000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-26000 usd
CY2022 next Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-678000 usd
CY2021 next Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-548000 usd
CY2022 next Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
5812000 usd
CY2021 next Increase Decrease In Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherLiabilities
4468000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40076000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17960000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33753000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12105000 usd
CY2022 next Investing Activities Other Noncurrent Assets
InvestingActivitiesOtherNoncurrentAssets
7135000 usd
CY2021 next Investing Activities Other Noncurrent Assets
InvestingActivitiesOtherNoncurrentAssets
6429000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40888000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18534000 usd
CY2022 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
10500000 usd
CY2021 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
39500000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
115000000 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
557000 usd
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3952000 usd
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
268000 usd
CY2022 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
75000 usd
CY2021 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
67000 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3272000 usd
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
284000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
118201000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39438000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
37237000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2944000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25552000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22608000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62789000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25552000 usd
CY2022 next Capital Expenditures Incurred But Not Yet Paid Included In Accounts Payable
CapitalExpendituresIncurredButNotYetPaidIncludedInAccountsPayable
162000 usd
CY2021 next Capital Expenditures Incurred But Not Yet Paid Included In Accounts Payable
CapitalExpendituresIncurredButNotYetPaidIncludedInAccountsPayable
117000 usd
CY2022 next Capital Expenditures Incurred But Not Yet Paid Included In Accrued Liabilities
CapitalExpendituresIncurredButNotYetPaidIncludedInAccruedLiabilities
12046000 usd
CY2021 next Capital Expenditures Incurred But Not Yet Paid Included In Accrued Liabilities
CapitalExpendituresIncurredButNotYetPaidIncludedInAccruedLiabilities
926000 usd
CY2022 next Capital Expenditures Incurred But Not Yet Paid Included In Noncurrent Assets
CapitalExpendituresIncurredButNotYetPaidIncludedInNoncurrentAssets
279000 usd
CY2021 next Capital Expenditures Incurred But Not Yet Paid Included In Noncurrent Assets
CapitalExpendituresIncurredButNotYetPaidIncludedInNoncurrentAssets
0 usd
CY2022 next Pipeline Assets In Exchange For Other Non Current Liabilities
PipelineAssetsInExchangeForOtherNonCurrentLiabilities
0 usd
CY2021 next Pipeline Assets In Exchange For Other Non Current Liabilities
PipelineAssetsInExchangeForOtherNonCurrentLiabilities
84000 usd
CY2022 next Noncash Paidinkind Dividends Convertible Preferred Stock
NoncashPaidinkindDividendsConvertiblePreferredStock
24207000 usd
CY2021 next Noncash Paidinkind Dividends Convertible Preferred Stock
NoncashPaidinkindDividendsConvertiblePreferredStock
18227000 usd
CY2022 next Noncash Accretion Of Deemed Dividends Convertible Preferred Stock
NoncashAccretionOfDeemedDividendsConvertiblePreferredStock
0 usd
CY2021 next Noncash Accretion Of Deemed Dividends Convertible Preferred Stock
NoncashAccretionOfDeemedDividendsConvertiblePreferredStock
63000 usd
CY2022 next Liabilities Accrued For Equity Issuance Costs
LiabilitiesAccruedForEquityIssuanceCosts
0 usd
CY2021 next Liabilities Accrued For Equity Issuance Costs
LiabilitiesAccruedForEquityIssuanceCosts
35000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62800000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><b>Use of Estimates</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The preparation of Consolidated Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the amounts reported in the Consolidated Financial Statements and the accompanying notes. Management evaluates its estimates and related assumptions regularly, including those related to the value of property, plant and equipment, income taxes including valuation allowances for net deferred tax assets, share-based compensation and fair value measurements. Changes in facts and circumstances or additional information <em style="font: inherit;"> may </em>result in revised estimates, and actual results <em style="font: inherit;"> may </em>differ from these estimates.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"> </p>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"/><p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;"/> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 7.2pt; text-align: left; text-indent: -9pt;"><b>Concentrations of Credit Risk</b></p> <p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Financial instruments that potentially subject us to a concentration of credit risk consist principally of cash and cash equivalents. We maintain cash and cash equivalent balances with a single financial institution, which <em style="font: inherit;"> may </em>at times be in excess of federally insured levels. We have <em style="font: inherit;">not</em> incurred losses related to these cash and cash equivalent balances to date.</p>
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
887000 usd
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
627000 usd
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
232000 usd
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
278000 usd
CY2022 us-gaap Lease Cost
LeaseCost
1119000 usd
CY2021 us-gaap Lease Cost
LeaseCost
905000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1823000 usd
CY2022Q4 next Prepaid Subscriptions
PrepaidSubscriptions
423000 usd
CY2021Q4 next Prepaid Subscriptions
PrepaidSubscriptions
85000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
619000 usd
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
376000 usd
CY2022Q4 next Prepaid Marketing And Sponsorships
PrepaidMarketingAndSponsorships
0 usd
CY2021Q4 next Prepaid Marketing And Sponsorships
PrepaidMarketingAndSponsorships
60000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
107000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
314000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1149000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
835000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1300000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
273000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
250000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
218646000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
173816000 usd
CY2022 us-gaap Depreciation
Depreciation
162000 usd
CY2021 us-gaap Depreciation
Depreciation
184000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1474000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
590000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1093000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
596000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1558000 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
596000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
265000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1558000 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1640000 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
712000 usd
CY2022Q4 next Permitting Costs Noncurrent
PermittingCostsNoncurrent
8575000 usd
CY2021Q4 next Permitting Costs Noncurrent
PermittingCostsNoncurrent
7609000 usd
CY2022Q4 next Enterprise Resource Planning System Noncurrent
EnterpriseResourcePlanningSystemNoncurrent
0 usd
CY2021Q4 next Enterprise Resource Planning System Noncurrent
EnterpriseResourcePlanningSystemNoncurrent
354000 usd
CY2022Q4 next Site Lease Initial Direct Costs
SiteLeaseInitialDirectCosts
19612000 usd
CY2021Q4 next Site Lease Initial Direct Costs
SiteLeaseInitialDirectCosts
13314000 usd
CY2022Q4 next Deposits And Other
DepositsAndOther
185000 usd
CY2021Q4 next Deposits And Other
DepositsAndOther
35000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
28372000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21312000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6650000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4358000 usd
CY2022Q4 next Project Asset Costs Current
ProjectAssetCostsCurrent
12046000 usd
CY2021Q4 next Project Asset Costs Current
ProjectAssetCostsCurrent
926000 usd
CY2022Q4 next Permitting Costs Current
PermittingCostsCurrent
-279000 usd
CY2021Q4 next Permitting Costs Current
PermittingCostsCurrent
-0 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3124000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
70000 usd
CY2022Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
182000 usd
CY2021Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
182000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
903000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
437000 usd
CY2022Q4 next Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
23184000 usd
CY2021Q4 next Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
5973000 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
10500000 usd
CY2022 next Payments Of Equity Issuance Costs
PaymentsOfEquityIssuanceCosts
-20000 usd
CY2022 next Proceeds From Issuance Of Convertible Preferred Stock And Common Stock Warrant Net
ProceedsFromIssuanceOfConvertiblePreferredStockAndCommonStockWarrantNet
10480000 usd
CY2021 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
39500000 usd
CY2021 next Payments Of Equity Issuance Costs
PaymentsOfEquityIssuanceCosts
-62000 usd
CY2021 next Proceeds From Issuance Of Convertible Preferred Stock And Common Stock Warrant Net
ProceedsFromIssuanceOfConvertiblePreferredStockAndCommonStockWarrantNet
39438000 usd
CY2022 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
-5700000 usd
CY2021 next Gain Loss On Revaluation Of Warrants
GainLossOnRevaluationOfWarrants
-2500000 usd
CY2022 next Stock Issued During Period Exercise Of Warrants Shares
StockIssuedDuringPeriodExerciseOfWarrantsShares
500000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
130136000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119201000
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
130136000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119201000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.65
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
49819000
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
46705000
CY2022 next Securities Excluded From Computation Of Earnings Per Share Amount Performance Conditions
SecuritiesExcludedFromComputationOfEarningsPerShareAmountPerformanceConditions
9400000
CY2021 next Securities Excluded From Computation Of Earnings Per Share Amount Performance Conditions
SecuritiesExcludedFromComputationOfEarningsPerShareAmountPerformanceConditions
8300000
CY2022 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards
7472000 usd
CY2021 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Equity Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostEquityAwards
-4541000 usd
CY2022 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Liability Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostLiabilityAwards
0 usd
CY2021 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost Liability Awards
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCostLiabilityAwards
0 usd
CY2022 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost
7472000 usd
CY2021 next Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost
-4541000 usd
CY2022 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-0 usd
CY2021 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
-228000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7472000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-4313000 usd
CY2022 next Percentage Of Fid Bonus Settlement Of Shares
PercentageOfFIDBonusSettlementOfShares
1.10 pure
CY2022Q4 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
200000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
48100000 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7104000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.31
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1261000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
6.17
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 next Effective Income Tax Rate Reconciliation Common Stock Warrant Liabilities
EffectiveIncomeTaxRateReconciliationCommonStockWarrantLiabilities
-0.02 pure
CY2021 next Effective Income Tax Rate Reconciliation Common Stock Warrant Liabilities
EffectiveIncomeTaxRateReconciliationCommonStockWarrantLiabilities
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.01 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.01 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.04 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.17 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.17 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q4 next Deferred Tax Assets Operating Loss Carryforwards And Credits
DeferredTaxAssetsOperatingLossCarryforwardsAndCredits
36835000 usd
CY2021Q4 next Deferred Tax Assets Operating Loss Carryforwards And Credits
DeferredTaxAssetsOperatingLossCarryforwardsAndCredits
25742000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1113000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
570000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1066000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2053000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
964000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
749000 usd
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
753000 usd
CY2022Q4 next Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
187000 usd
CY2021Q4 next Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
125000 usd
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
36000 usd
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
55000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36642000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
26378000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4308000 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
2920000 usd
CY2022Q4 next Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
4308000 usd
CY2021Q4 next Deferred Tax Liabilities Operating Leases
DeferredTaxLiabilitiesOperatingLeases
2920000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
4308000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2920000 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
175400000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
26100000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
next-20221231_cal.xml Edgar Link unprocessable
0001437749-23-006171-index-headers.html Edgar Link pending
0001437749-23-006171-index.html Edgar Link pending
0001437749-23-006171.txt Edgar Link pending
0001437749-23-006171-xbrl.zip Edgar Link pending
abbreviatedorgchartforkandqm.jpg Edgar Link pending
ex_450157.htm Edgar Link pending
ex_450158.htm Edgar Link pending
ex_450159.htm Edgar Link pending
ex_450160.htm Edgar Link pending
ex_450161.htm Edgar Link pending
ex_450162.htm Edgar Link pending
ex_450163.htm Edgar Link pending
ex_450164.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
next-20221231.xsd Edgar Link pending
next20221122_10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
next-20221231_def.xml Edgar Link unprocessable
next-20221231_lab.xml Edgar Link unprocessable
next-20221231_pre.xml Edgar Link unprocessable
next20221122_10k_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending